Abstract
There is widespread concern in Australia and internationally at the high prevalence of psychotropic medication use in residential aged care facilities. It is difficult for nurses and general practitioners in aged care facilities to cease new residents’ psychotropic medications when they often have no information about why residents were started on the treatment, when and by whom and with what result. Most existing interventions have had a limited and temporary effect and there is a need to test different strategies to overcome the structural and practical barriers to psychotropic medication cessation or deprescribing. In this chapter, we review the literature regarding psychotropic medication deprescribing in aged care facilities and present the protocol of a novel study that will examine the potential role of family members in facilitating deprescribing. This project will help determine if family members can contribute information that will prove useful to clinicians and thereby overcome one of the barriers to deprescribing medications whose harmful effects often outweigh their benefits. We wish to understand the knowledge and attitudes of family members regarding the prescribing and deprescribing of psychotropic medications to newly admitted residents of aged care facilities with a view to developing and testing a range of clinical interventions that will result in better, safer prescribing practices.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Australian Institute of Health and Welfare (2013) Residential aged care and aged care packages in the community 2011–12 [Online]. http://www.aihw.gov.au/aged-care/residential-and-community-2011-12/. Accessed 11 Feb 2014
Hosia-Randell H, Pitkala K (2005) Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 22(9):793–800
Snowdon J, Galanos D, Vaswani D (2011) Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries. Int Psychogeriatr 23(9):1520–1525
Rattinger GB, Burcu M, Dutcher SK, Chhabra PT, Rosenberg PB, Simoni-Wastila L et al (2013) Pharmacotherapeutic management of dementia across settings of care. J Am Geriatr Soc 61(5):723–733
Wood-Mitchell A, James IA, Waterworth A, Swann A, Ballard C (2008) Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. Age Ageing 37(5):547–552
Kaur S, Mitchell G, Vitetta L, Roberts MS (2009) Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 26(12):1013–1028
Brulhart MI, Wermeille JP (2011) Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm 33(3):549–557
Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD (2013) Development and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm 35(1):51–56
Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S (2013) People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc 61(9):1508–1514
Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD (2013) Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 30(10):793–807
Woodward M (2003) Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 33(4):323–328
Alexander GC, Sayla MA, Holmes HM, Sachs GA (2006) Prioritizing and stopping prescription medicines. CMAJ 174(8):1083–1084
Ostini R, Hegney D, Jackson C, Williamson M, Mackson JM, Gurman K et al (2009) Systematic review of interventions to improve prescribing. Ann Pharmacother 43(3):502–513
Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG (2008) Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 56(10):1946–1952
Le Couteur D, Banks E, Gnjidic D, McLachlan A (2011) Deprescribing. Aust Prescr 34:182–185
Ostini R, Hegney D, Jackson C, Tett SE (2012) Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manag Care Pharm 18(1):68–72
Scott IA, Gray LC, Martin JH, Mitchell CA (2012) Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med 125(6):529–537e4
Draper B, Brodaty H, Low LF (2006) A tiered model of psychogeriatric service delivery: an evidence-based approach. Int J Geriatr Psychiatry 21(7):645–653
Hartikainen S, Lonnroos E, Louhivuori K (2007) Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 62(10):1172–1181
Taipale HT, Bell JS, Gnjidic D, Sulkava R, Hartikainen S (2012) Sedative load among community-dwelling people aged 75 years or older: association with balance and mobility. J Clin Psychopharmacol 32(2):218–224
Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS (2007) Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 176(5):627–632
The Royal Australian and New Zealand College of Psychiatrists (2009) Practice Guideline 10: Antipsychotic medications as a treatment of behavioural and psychological symptoms in dementia [Online]. https://www.ranzcp.org/Resources/Statements-Guidelines/Practice-Guidelines.aspx. Accessed 09 Feb 2014
Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML et al (2013) Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev 3:CD007726
O’Connor DW, Griffith J, McSweeney K (2010) Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia. Int Psychogeriatr 22(7):1149–1153
Maguire A, Hughes C, Cardwell C, O’Reilly D (2013) Psychotropic medications and the transition into care: a national data linkage study. J Am Geriatr Soc 61(2):215–221
Azermai M, Vander Stichele RRH, Van Bortel LM, Elseviers MM (2013) Barriers to antipsychotic discontinuation in nursing homes: an exploratory study. Aging Ment Health 18:346–353. http://dx.doi.org/10.1080/13607863.2013.832732
Hilmer SN, Gnjidic D, Le Couteur DG (2012) Thinking through the medication list—appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam Physician 41(12):924–928
The Department of Health (2012) Guiding principles for medication management in residential aged care facilities [Online]. http://www.health.gov.au/internet/main/publishing.nsf/Content/nmp-pdf-resguide-cnt.htm Accessed 09 Feb 2014
Tjia J, Gurwitz JH, Briesacher BA (2012) Challenge of changing nursing home prescribing culture. Am J Geriatr Pharmacother 10(1):37–46
Rovner BW, Edelman BA, Cox MP, Shmuely Y (1992) The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 149(10):1390–1392
Rendina N, Brodaty H, Draper B, Peisah C, Brugue E (2009) Substitute consent for nursing home residents prescribed psychotropic medication. Int J Geriatr Psychiatry 24(3):226–231
Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H et al (2004) An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 33(6):612–617
Nishtala PS, McLachlan AJ, Bell JS, Chen TF (2008) Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 16(8):621–632
Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP et al (2001) Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 51(3):257–265
Crotty M, Whitehead C, Rowett D, Halbert J, Weller D, Finucane P et al (2004) An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial [ISRCTN67855475]. BMC Health Serv Res 4(1):6
Westbury J, Jackson S, Gee P, Peterson G (2010) An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr 22(1):26–36
Westbury J, Tichelaar L, Peterson G, Gee P, Jackson S (2011) A 12-month follow-up study of “RedUSe”: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr 23(8):1260–1269
Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F et al (2007) Designing and evaluating complex interventions to improve health care. BMJ 334(7591):455–459
National Health and Medical Research Council (2007) National statement on ethical conduct in human research (2007) - Updated December 2013 [Online]. http://www.nhmrc.gov.au/guidelines/publications/e72. Accessed 09 Feb 2014
Alzheimer's Australia (2013) Participate in research [Online]. http://www.fightdementia.org.au/research-publications/clinical-trials--research-projects.aspx. Accessed 09 Feb 2014
Gale NK, Heath G, Cameron E, Rashid S, Redwood S (2013) Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 13:117
Cumbler E, Wald H, Kutner J (2010) Lack of patient knowledge regarding hospital medications. J Hosp Med 5(2):83–86
Acknowledgements
This project has been funded by the Lions John Cockayne Memorial Fellowship Trust Fund.
The Lions John Cockayne Memorial Fellowship Trust is jointly funded by Oakleigh Lions Club Elderly Peoples Home Inc. and Monash Health.
Conflicts of Interest: The authors report no conflicts of interest and are alone responsible for the content and writing of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Plakiotis, C., Bell, J.S., Jeon, YH., Pond, D., O’Connor, D.W. (2015). Deprescribing Psychotropic Medications in Aged Care Facilities: The Potential Role of Family Members. In: Vlamos, P., Alexiou, A. (eds) GeNeDis 2014. Advances in Experimental Medicine and Biology, vol 821. Springer, Cham. https://doi.org/10.1007/978-3-319-08939-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-08939-3_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-08938-6
Online ISBN: 978-3-319-08939-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)